With the analysis among 98 patents, we discovered top 53 key players by total patent application. EngMab SARL, Bio-Thera Solutions, Ltd., Bristol Myers Squibb Co. are dominant in this area. They take 18.37% of the total patent filing.
Schwyz, Switzerland
Patent: 9
Guangdong Sheng, China
Patent: 5
New York, United States
Patent: 4
California, United States
Patent: 3
Washington, United States
Patent: 3
Vaud, Switzerland
Patent: 3
Antwerpen, Belgium
Patent: 3
With the analysis among 3 patents, we discovered top 2 start-ups by total patent application.
With the analysis among related 51 patents applied in the last 5 years. We discover 34 most active companies in this area. The fast-growing EngMab SARL, LegoChem Biosciences, Inc., Centre of Molecular Immunology take 27.45% of patent filing during this period.
Schwyz, Switzerland
Patent: 6
New York, United States
Patent: 2
EPIMAB BIOTHERAPEUTICS (HK)LIMITED
undefined undefined
Patent: 2
ZURICH, Switzerland
Patent: 2
EpimAb Biotherapeutics (Suzhou) Co. Ltd.
Antwerpen, Belgium
Patent: 2
Shanghai Shi, China
Patent: 2
With the analysis among related 51 patents in last 5 years, we discover 25 new entrants. LegoChem Biosciences, Inc., Centre of Molecular Immunology, YBiologics, Inc. are the most active new entrants in this area.
EPIMAB BIOTHERAPEUTICS (HK)LIMITED
undefined undefined
Patent: 2
ZURICH, Switzerland
Patent: 2
EpimAb Biotherapeutics (Suzhou) Co. Ltd.
Shanghai Shi, China
Patent: 2
With the analysis among 27 patents, we discovered top 3 universities and scientific research institutions by total patent application.
New York, United States
Patent: 3